S14 Ep47: Gynecologic Oncology Surgery Advances Are Propelled by Minimally Invasive Techniques: With Ursula Matulonis,

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/37/d9/f9/37d9f9c6-c820-66f3-7a4b-459aefa0484a/mza_9223874801391949533.jpg/600x600bb.jpg

OncLive® On Air

500 episodes

3 days ago

Dr Erba discusses the FDA approval of ziftomenib for the treatment of adult patients with relapsed/refractory AML with a susceptible NPM1 mutation.

Health & Fitness

Science

RSS

All content for OncLive® On Air is the property of OncLive® On Air and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Dr Erba discusses the FDA approval of ziftomenib for the treatment of adult patients with relapsed/refractory AML with a susceptible NPM1 mutation.

Health & Fitness

Science

https://audioboom.com/i/43193613/s=1400x1400/el=1/rt=fill.jpg

S14 Ep47: Gynecologic Oncology Surgery Advances Are Propelled by Minimally Invasive Techniques: With Ursula Matulonis,

OncLive® On Air

19 minutes

1 week ago

S14 Ep47: Gynecologic Oncology Surgery Advances Are Propelled by Minimally Invasive Techniques: With Ursula Matulonis,

In the inaugural episode of this new podcast series, Drs Matulonis and May discuss advances in gynecologic cancer surgery.